von Bardeleben R S, Tiemann K
Medizinische Klinik - Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsmedizin Mainz, Johannes Gutenberg-Universität, Langenbeckstrasse 1, Mainz, Germany.
Herz. 2013 Jun;38(4):334-43. doi: 10.1007/s00059-013-3813-3.
Early detection of prognostically significant coronary artery disease (CAD) using ischemic tests, including noninvasive cardiac imaging, are fundamental approaches of optimized patient treatment guidelines to lower morbidity and mortality of these patients. Current international guidelines and the national standard of care guidelines from 2006 and 2011 as well as the third universal definition of myocardial infarction stress the increasing role of echocardiography as a favorable noninvasive imaging test. Echocardiography at rest, ergometric and pharmacologic stress echocardiography are established and readily available diagnostic tools with the potential to evaluate global and regional left ventricular function at rest and during exercise combined with information regarding regional perfusion. Especially new data on perfusion analysis allow further extension of the indications spectrum of reperfusion analysis and sensitivity increases in chest pain unit settings. The noninvasive detection of significant and prognostic stenosis burden in CAD without radiation is possible with high sensitivity and good specificity and encompasses functional cardiovascular parameters as well as extension of the ischemic area.The likelihood of future cardiac events can be assessed with high negative predictive accuracy, giving a high safety aspect in the treatment options of patients. The diagnostic potential of stress echocardiography is best in patients with intermediate and higher pretest probabilities. In patients under concurrent antiischemic medication identification of high risk patients seems feasible. Stress echocardiography has an excellent specificity and prognostic value for either indications for revascularization or survival prediction as well as survival benefits after revascularization in test positive patients.The detection of pathologic findings is not impaired by gender differences. New technical approaches include 2-D and 3-D speckle analysis of the myocardial wall and contrast-enhanced improvements in myocardial border delineation and perfusion. A new European multicenter study published in 2013 could demonstrate comparable to improved sensitivities in intermediate to severe coronary stenosis from 50% to 70% and in highly obstructive proximal stenoses compared to a reference electrocardiogram (ECG)-gated single photon emission computed tomography (SPECT).
利用包括无创心脏成像在内的缺血检测手段早期发现具有预后意义的冠状动脉疾病(CAD),是优化患者治疗指南以降低这些患者发病率和死亡率的基本方法。当前的国际指南以及2006年和2011年的国家护理标准指南,还有心肌梗死的第三次通用定义,都强调了超声心动图作为一种良好的无创成像检测手段的作用日益增加。静息超声心动图、运动负荷和药物负荷超声心动图是已确立且易于获得的诊断工具,有潜力评估静息及运动时的整体和局部左心室功能,并结合有关局部灌注的信息。尤其是灌注分析的新数据使得再灌注分析的适应证范围得以进一步扩展,并且在胸痛单元环境中敏感性有所提高。在无辐射的情况下,以高灵敏度和良好的特异性无创检测CAD中具有显著意义和预后意义的狭窄负荷是可行的,这包括功能性心血管参数以及缺血区域的扩展。未来心脏事件的可能性可以通过高阴性预测准确性进行评估,这在患者的治疗选择中提供了很高的安全性。负荷超声心动图的诊断潜力在预检概率为中等及较高的患者中最佳。对于正在接受抗缺血药物治疗的患者,识别高危患者似乎是可行的。负荷超声心动图对于血管重建适应证或生存预测以及血管重建后试验阳性患者的生存获益具有出色的特异性和预后价值。病理结果的检测不受性别差异的影响。新的技术方法包括心肌壁的二维和三维散斑分析以及心肌边界描绘和灌注方面的对比增强改进。2013年发表的一项新的欧洲多中心研究表明,与参考心电图(ECG)门控单光子发射计算机断层扫描(SPECT)相比,对于中度至重度冠状动脉狭窄,灵敏度可提高到50%至70%,对于高度阻塞性近端狭窄,灵敏度也有所提高。